China Resources Pharmaceutical Group (FRA:640) Beginning Cash Position : €2,924 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group Beginning Cash Position?

China Resources Pharmaceutical Group's Beginning Cash Position for the quarter that ended in Dec. 2024 was €2,924 Mil.

China Resources Pharmaceutical Group's quarterly Beginning Cash Position increased from Dec. 2023 (€2,834 Mil) to Jun. 2024 (€3,157 Mil) but then declined from Jun. 2024 (€3,157 Mil) to Dec. 2024 (€2,924 Mil).

China Resources Pharmaceutical Group's annual Beginning Cash Position increased from Dec. 2022 (€1,938 Mil) to Dec. 2023 (€1,955 Mil) and increased from Dec. 2023 (€1,955 Mil) to Dec. 2024 (€3,233 Mil).

China Resources Pharmaceutical Group Beginning Cash Position Historical Data

The historical data trend for China Resources Pharmaceutical Group's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Pharmaceutical Group Beginning Cash Position Chart

China Resources Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

1,329.29

1,275.62

1,938.45

1,955.15

3,233.40

China Resources Pharmaceutical Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															2,044.66	1,962.12	2,833.70	3,156.64	2,924.02

China Resources Pharmaceutical Group Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

China Resources Pharmaceutical Group Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (FRA:640) » Definitions » Beginning Cash Position

Traded in Other Exchanges

03320:Hong Kong 640:Germany

Address

26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, HKG

Website

https://www.crpharm.com

China Resources Pharmaceutical is the third-largest medical distributor in China by revenue. It is an integrated pharmaceutical company specializing in research and development, manufacturing, medical distribution, and retail pharmacies. As of 2024, the medical distribution business accounts for 82.8% of its total revenue. CR Pharma's manufacturing business, 18.0% of total revenue, has subsidiaries with a strong presence in traditional Chinese medicine and consumer healthcare.

China Resources Pharmaceutical Group Headlines

No Headlines